Endoscopic Therapy of Neoplasia Related to Barrett's Esophagus and Endoscopic Palliation of Esophageal Cancer

Spechler S.J. , Goyal R.K. . Barrett's esophagus. N Engl J Med. 1986; 315(6): 362–371.

Haggitt R.C. . Adenocarcinoma in Barrett's esophagus: a new epidemic? Hum Pathol. 1992; 23(5): 475–476.

Haggitt R.C. , Tryzelaar J. , Ellis F.H. . Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus. Am J Clin Pathol. 1978; 70(1): 1–5.

Blot W.J. . Esophageal cancer trends and risk factors. Semin Oncol. 1994; 21(4): 403–410.

Solaymani-Dodaran M. , Logan R.F. , West J. . Risk of esophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux. Gut. 2004; 53(8): 1070–1074.

Iftikhar S.Y. , James P.D. , Steele R.J. . Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut. 1992; 33(9): 1155–1158.

Sampliner R.E. . Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol. 2002; 97(8): 1888–1895.

Hameeteman W. , Tytgat G.N. , Houthoff H.J. . Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology. 1989; 96(5 Pt 1): 1249–1256.

Reid B.J. , Blount P.L. , Rubin C.E. . Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. Gastroenterology. 1992; 102(4 Pt 1): 1212–1219.

Skacel M. , Petras R.E. , Gramlich T.L. . The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression. Am J Gastroenterol. 2000; 95(12): 3383–3387.

Montgomery E. , Bronner M.P. , Goldblum J.R. . Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol. 2001; 32(4): 368–378.

Sharma P. , Morales T.G. , Sampliner R.E. . Short segment Barrett's esophagus–the need for standardization of the definition and of endoscopic criteria. Am J Gastroenterol. 1998; 93(7): 1033–1036.

Weston A.P. , Krmpotich P. , Makdisi W.F. . Short segment Barrett's esophagus: clinical and histological features, associated endoscopic findings, and association with gastric intestinal metaplasia. Am J Gastroenterol. 1996; 91(5): 981–986.

Pech O. , Behrens A. , May A. . Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut. 2008; 57(9): 1200–1206.

Sharma P. , Dent J. , Armstrong D. . The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology. 2006; 131(5): 1392–1399.

Konda V.J. , Ross A.S. , Ferguson M.K. . Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett's esophagus overestimated? Clin Gastroenterol Hepatol. 2008; 6(2): 159–164.

Nigro J.J. , Hagen J.A. , DeMeester T.R. . Occult esophageal adenocarcinoma: extent of disease and implications for effective therapy. Ann Surg. 1999; 230(3): 433–440.

Tharavej C. , Hagen J.A. , Peters J.H. . Predictive factors of coexisting cancer in Barrett's high-grade dysplasia. Surg Endosc. 2006; 20(3): 439–443.

Peters F.P. , Brakenhoff K.P. , Curvers W.L. . Histologic evaluation of resection specimens obtained at 293 endoscopic resections in Barrett's esophagus. Gastrointest Endosc. 2008; 67(4): 604–609.

Reid B.J. , Weinstein W.M. , Lewin K.J. . Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology. 1988; 94(1): 81–90.

Schmidt H.G. , Riddell R.H. , Walther B. . Dysplasia in Barrett's esophagus. J Cancer Res Clin Oncol. 1985; 110(2): 145–152.

Smith R.R. , Hamilton S.R. , Boitnott J.K. . The spectrum of carcinoma arising in Barrett's esophagus. A clinicopathologic study of 26 patients. Am J Surg Pathol. 1984; 8(8): 563–573.

American Joint Committee on Cancer Staging Manual. 7th ed. Edge S.B. , Byrd D.R. , Compton C.C. , eds. Springer: New York, NY; 2010.

Ancona E. , Rampado S. , Cassaro M. . Prediction of lymph node status in superficial esophageal carcinoma. Ann Surg Oncol. 2008; 15(11): 3278–3288.

Eguchi T. , Nakanishi Y. , Shimoda T. . Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases. Mod Pathol. 2006; 19(3): 475–480.

Bergman J.J. , Fockens P. . Endoscopic ultrasonography in patients with gastro-esophageal cancer. Eur J Ultrasound. 1999; 10(2-3): 127–138.

Pouw R.E. , Heldoorn N. , Herrero L.A. . Do we still need EUS in the workup of patients with early esophageal neoplasia? A retrospective analysis of 131 cases. Gastrointest Endosc. 2011; 73(4): 662–668.

Shami V.M. , Villaverde A. , Stearns L. . Clinical impact of conventional endosonography and endoscopic ultrasound-guided fine-needle aspiration in the assessment of patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma who have been referred for endoscopic ablation therapy. Endoscopy. 2006; 38(2): 157–161.

May A , Günter E , Roth F . Accuracy of staging in early oesophageal cancer using high resolution endoscopy and high resolution endosonography: a comparative, prospective, and blinded trial. Gut. 2004; 53(5): 634–640.

Wang V.S. , Hornick J.L. , Sepulveda J.A. . Low prevalence of submucosal invasive carcinoma at esophagectomy for high-grade dysplasia or intramucosal adenocarcinoma in Barrett's esophagus: a 20-year experience. Gastrointest Endosc. 2009; 69(4): 777–783.

Edwards M.J. , Gable D.R. , Lentsch A.B. . The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia. Ann Surg. 1996; 223(5): 585–591.

Rice T.W. , Falk G.W. , Achkar E. . Surgical management of high-grade dysplasia in Barrett's esophagus. Am J Gastroenterol. 1993; 88(11): 1832–1836.

Ferguson M.K. , Naunheim K.S. . Resection for Barrett's mucosa with high-grade dysplasia: implications for prophylactic photodynamic therapy. J Thorac Cardiovasc Surg. 1997; 114(5): 824–829.

Chennat J. , Konda V.J. , Ross A.S. . Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma–an American single-center experience. Am J Gastroenterol. 2009; 104(11): 2684–2692.

Finks J.F. , Osborne N.H. , Birkmeyer J.D. . Trends in hospital volume and operative mortality for high-risk surgery. N Engl J Med. 364(22): 2128–2137.

Birkmeyer J.D. , Siewers A.E. , Finlayson E.V. . Hospital volume and surgical mortality in the United States. N Engl J Med. 2002; 346(15): 1128–1137.

Pouw R.E. , van Vilsteren F.G. , Peters F.P. . Randomized trial on endoscopic resection-cap versus multiband mucosectomy for piecemeal endoscopic resection of early Barrett's neoplasia. Gastrointest Endosc. 2011; 74(1): 35–43.

Moss A. , Bourke M.J. , Hourigan L.F. . Endoscopic resection for Barrett's high-grade dysplasia and early esophageal adenocarcinoma: an essential staging procedure with long-term therapeutic benefit. Am J Gastroenterol. 2010; 105(6): 1276–1283.

Prasad G.A. , Buttar N.S. , Wongkeesong L.M. . Significance of neoplastic involvement of margins obtained by endoscopic mucosal resection in Barrett's esophagus. Am J Gastroenterol. 2007; 102(11): 2380–2386.

Ell C. , May A. , Pech O. . Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). Gastrointest Endosc. 2007; 65(1): 3–10.

Vieth M. , Ell C. , Gossner L. . Histological analysis of endoscopic resection specimens from 326 patients with Barrett's esophagus and early neoplasia. Endoscopy. 2004; 36(9): 776–781.

May A. , Gossner L. , Behrens A. . A prospective randomized trial of two different endoscopic resection techniques for early stage cancer of the esophagus. Gastrointest Endosc. 2003; 58(2): 167–175.

Nigro J.J. , Hagen J.A. , DeMeester T.R. . Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy. J Thorac Cardiovasc Surg. 1999; 117(1): 16–25.

Nigro J.J. , DeMeester S.R. , Hagen J.A. . Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy. J Thorac Cardiovasc Surg. 1999; 117(5): 960–968.

Holscher A.H. , Bollschweiler E. , Schneider P.M. . Early adenocarcinoma in Barrett's oesophagus. Br J Surg. 1997; 84(10): 1470–1473.

Paraf F. , Flejou J.F. , Pignon J.P. . Surgical pathology of adenocarcinoma arising in Barrett's esophagus. Analysis of 67 cases. Am J Surg Pathol. 1995; 19(2): 183–191.

Wani S. , Mathur S.C. , Curvers W.L. . Greater interobserver agreement by endoscopic mucosal resection than biopsy samples in Barrett's dysplasia. Clin Gastroenterol Hepatol. 2010; 8(9): 783–788.

Mino-Kenudson M. , Hull M.J. , Brown I. . EMR for Barrett's esophagus-related superficial neoplasms offers better diagnostic reproducibility than mucosal biopsy. Gastrointest Endosc. 2007; 66(4): 660–666.

Maish M.S. , DeMeester S.R. . Endoscopic mucosal resection as a staging technique to determine the depth of invasion of esophageal adenocarcinoma. Ann Thorac Surg. 2004; 78(5): 1777–1782.

Hull M.J. , Mino-Kenudson M. , Nishioka N.S. . Endoscopic mucosal resection: an improved diagnostic procedure for early gastroesophageal epithelial neoplasms. Am J Surg Pathol. 2006; 30(1): 114–118.

Alvarez Herrero L. , Pouw R.E. , van Vilsteren F.G. . Safety and efficacy of multiband mucosectomy in 1060 resections in Barrett's esophagus. Endoscopy. 2011; 43(3): 177–83.

Manner H. , May A. , Pech O. . Early Barrett's carcinoma with “low-risk” submucosal invasion: long-term results of endoscopic resection with a curative intent. Am J Gastroenterol. 2008; 103(10): 2589–2597.

Ell C. , May A. , Gossner L. . Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology. 2000; 118(4): 670–677.

Esaki M. , Matsumoto T. , Hirakawa K. . Risk factors for local recurrence of superficial esophageal cancer after treatment by endoscopic mucosal resection. Endoscopy. 2007; 39(1): 41–45.

Buskens C.J. , Westerterp M. , Lagarde S.M. . Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features. Gastrointest Endosc. 2004; 60(5): 703–710.

Miyamoto S. , Muto M. , Hamamoto Y. . A new technique for endoscopic mucosal resection with an insulated-tip electrosurgical knife improves the completeness of resection of intramucosal gastric neoplasms. Gastrointest Endosc. 2002; 55(4): 576–581.

Hirasawa K. , Kokawa A. , Oka H. . Superficial adenocarcinoma of the esophagogastric junction: long-term results of endoscopic submucosal dissection. Gastrointest Endosc. 72(5): 960–966.

Lewis J.J. , Rubenstein J.H. , Singal A.G. . Factors associated with esophageal stricture formation after endoscopic mucosal resection for neoplastic Barrett's esophagus. Gastrointest Endosc. 2011; 74(4): 753–760.

Gerke H. , Siddiqui J. , Nasr I. . Efficacy and safety of EMR to completely remove Barrett's esophagus: experience in 41 patients. Gastrointest Endosc. 2011; 74(4): 761–771.

Katada C. , Muto M. , Manabe T. . Esophageal stenosis after endoscopic mucosal resection of superficial esophageal lesions. Gastrointest Endosc. 2003; 57(2): 165–169.

Shaheen N.J. , Sharma P. , Overholt B.F. . Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med. 2009; 360(22): 2277–2288.

Ganz R.A. , Utley D.S. , Stern R.A. . Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: a phased evaluation in the porcine and in the human esophagus. Gastrointest Endosc. 2004; 60(6): 1002–1010.

Dunkin B.J. , Martinez J. , Bejarano P.A. . Thin-layer ablation of human esophageal epithelium using a bipolar radiofrequency balloon device. Surg Endosc. 2006; 20(1): 125–130.

Sharma V.K. , Kim H.J. , Das A. . A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system). Endoscopy. 2008; 40(5): 380–387.

Ganz R.A. , Overholt B.F. , Sharma V.K. . Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry. Gastrointest Endosc. 2008; 68(1): 35–40.

Semlitsch T. , Jeitler K. , Schoefl R. . A systematic review of the evidence for radiofrequency ablation for Barrett's esophagus. Surg Endosc. 2010; 24(12): 2935–2943.

Shaheen N.J. , Spechler S.J. . Total endoscopic eradication of Barrett's esophagus: study methodology, candidate selection, and clinical outcomes. Endoscopy. 2008; 40(12): 994–999.

Dunn J.M. , Banks M.R. , Oukrif D. . Radiofrequency ablation is effective for the treatment of high-grade dysplasia in Barrett's esophagus after failed photodynamic therapy. Endoscopy. 2011; 43(7): 627–630.

Overholt B.F. , Lightdale C.J. , Wang K.K. . Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc. 2005; 62(4): 488–498.

Overholt B.F. , Wang K.K. , Burdick J.S. . Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. Gastrointest Endosc. 2007; 66(3): 460–468.

Lovat L.B. , Jamieson N.F. , Novelli M.R. . Photodynamic therapy with m-tetrahydroxyphenyl chlorin for high-grade dysplasia and early cancer in Barrett's columnar lined esophagus. Gastrointest Endosc. 2005; 62(4): 617–623.

Mackenzie G.D. , Jamieson N.F. , Novelli M.R. . How light dosimetry influences the efficacy of photodynamic therapy with 5-aminolaevulinic acid for ablation of high-grade dysplasia in Barrett's esophagus. Lasers Med Sci. 2008; 23(2): 203–210.

Greenwald B.D. , Dumot J.A. , Abrams J.A. . Endoscopic spray cryotherapy for esophageal cancer: safety and efficacy. Gastrointest Endosc. 2010; 71(4): 686–693.

Shaheen N.J. , Greenwald B.D. , Peery A.F. . Safety and efficacy of endoscopic spray cryotherapy for Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc. 2010; 71(4): 680–685.

Greenwald B.D. , Dumot J.A. , Horwhat J.D. . Safety, tolerability, and efficacy of endoscopic low-pressure liquid nitrogen spray cryotherapy in the esophagus. Dis Esophagus. 2010; 23(1): 13–19.

Johnston M.H. , Eastone J.A. , Horwhat J.D. . Cryoablation of Barrett's esophagus: a pilot study. Gastrointest Endosc. 2005; 62(6): 842–848.

Dumot J.A. , Vargo J.J. 2nd , Falk G.W. . An open-label, prospective trial of cryospray ablation for Barrett's esophagus high-grade dysplasia and early esophageal cancer in high-risk patients. Gastrointest Endosc. 2009; 70(4): 635–44.

Barthel J.S. , Kucera S. , Harris C. . Cryoablation of persistent Barrett's epithelium after definitive chemoradiation therapy for esophageal adenocarcinoma. Gastrointest Endosc. 2011; 74(1): 51–57.

Chen A.M. , Pasricha P.J. . Cryotherapy for Barrett's esophagus: who, how, and why? Gastrointest Endosc Clin North Am. 2011; 21(1): 111–118.

Lightdale C.J. , Heier S.K. , Marcon N.E. . Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd: YAG laser for palliation of esophageal cancer: a multicenter randomized trial. Gastrointest Endosc. 1995; 42(6): 507–512.

Cash B.D. , Johnston L.R. , Johnston M.H. . Cryospray ablation (CSA) in the palliative treatment of squamous cell carcinoma of the esophagus. World J Surg Oncol. 2007; 5: 34.

Sharma P. , Kozarek R. . Role of esophageal stents in benign and malignant diseases. Am J Gastroenterol. 2010; 105(2): 258–273.

Brown R.E. , Abbas A.E. , Ellis S. . A prospective phase II evaluation of esophageal stenting for neoadjuvant therapy for esophageal cancer: optimal performance and surgical safety. J Am Coll Surg. 2011; 212(4): 582–589.

Acunas B. , Rozanes I. , Akpinar S. . Palliation of malignant esophageal strictures with self-expanding nitinol stents: drawbacks and complications. Radiology. 1996; 199(3): 648–652.

Saxon R.R. , Morrison K.E. , Lakin P.C. . Malignant esophageal obstruction and esophagorespiratory fistula: palliation with a polyethylene-covered Z-stent. Radiology. 1997; 202(2): 349–354.

Rozanes I. , Poyanli A. , Acunas B. . Palliative treatment of inoperable malignant esophageal strictures with metal stents: one center's experience with four different stents. Eur J Radiol. 2002; 43(3): 196–203.

Raijman I. , Siddique I. , Ajani J. . Palliation of malignant dysphagia and fistulae with coated expandable metal stents: experience with 101 patients. Gastrointest Endosc. 1998; 48(2): 172–179.

Verschuur E.M. , Kuipers E.J. , Siersema P.D. . Esophageal stents for malignant strictures close to the upper esophageal sphincter. Gastrointest Endosc. 2007; 66(6): 1082–1090.

Sreedharan A. , Harris K. , Crellin A. . Interventions for dysphagia in oesophageal cancer. Cochrane Database Syst Rev. 2009; (4): CD005048.

Ramirez F.C. , Dennert B. , Zierer S.T. . Esophageal self-expandable metallic stents–indications, practice, techniques, and complications: results of a national survey. Gastrointest Endosc. 1997; 45(5): 360–364.